Загрузка...
Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
We assessed the utility of droplet digital PCR (ddPCR) to evaluate the potential of using circulating tumour DNA (ctDNA) as a post therapy monitoring tool in melanoma by comparing it to serum LDH levels and RECIST scores. ddPCR was shown to be reliable in distinguishing mutant from wild type alleles...
Сохранить в:
Опубликовано в: : | Sci Rep |
---|---|
Главные авторы: | , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Nature Publishing Group
2015
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4476039/ https://ncbi.nlm.nih.gov/pubmed/26095797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep11198 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|